| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase II trial with RFS2000 (rubitecan) in patients with advanced non-small cell lung cancer
|
Baka, S.
|
|
2005
|
41 |
11 |
p. 1547-1550
4 p.
|
article
|
| 2 |
Assessment of the value of confirming responses in clinical trials in oncology
|
Perez-Gracia, Jose Luis
|
|
2005
|
41 |
11 |
p. 1528-1532
5 p.
|
article
|
| 3 |
Calendar
|
|
|
2005
|
41 |
11 |
p. I-II
nvt p.
|
article
|
| 4 |
Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
|
Hughes, Dyfrig A.
|
|
2005
|
41 |
11 |
p. 1655-
1 p.
|
article
|
| 5 |
Confirmation of response in cancer clinical trials: A meaningless exercise?
|
Therasse, P.
|
|
2005
|
41 |
11 |
p. 1501-1502
2 p.
|
article
|
| 6 |
Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma
|
O’Kane, S.L.
|
|
2005
|
41 |
11 |
p. 1645-1648
4 p.
|
article
|
| 7 |
Editorial board
|
|
|
2005
|
41 |
11 |
p. ii-
1 p.
|
article
|
| 8 |
Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial
|
Savonije, J.H.
|
|
2005
|
41 |
11 |
p. 1560-1569
10 p.
|
article
|
| 9 |
EJC issue 11, 2005
|
|
|
2005
|
41 |
11 |
p. 1495-1499
5 p.
|
article
|
| 10 |
Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer
|
Burger, Angelika M.
|
|
2005
|
41 |
11 |
p. 1515-1527
13 p.
|
article
|
| 11 |
Forthcoming papers
|
|
|
2005
|
41 |
11 |
p. xiv-
1 p.
|
article
|
| 12 |
Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells
|
Buc, E.
|
|
2005
|
41 |
11 |
p. 1618-1627
10 p.
|
article
|
| 13 |
Hereditary breast cancer growth rates and its impact on screening policy
|
Tilanus-Linthorst, Madeleine M.A.
|
|
2005
|
41 |
11 |
p. 1610-1617
8 p.
|
article
|
| 14 |
Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations
|
Krutilkova, Vera
|
|
2005
|
41 |
11 |
p. 1597-1603
7 p.
|
article
|
| 15 |
In this issue
|
|
|
2005
|
41 |
11 |
p. xiii-
1 p.
|
article
|
| 16 |
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy
|
Kellie, Stewart J.
|
|
2005
|
41 |
11 |
p. 1588-1596
9 p.
|
article
|
| 17 |
Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer
|
Chau, Ian
|
|
2005
|
41 |
11 |
p. 1551-1559
9 p.
|
article
|
| 18 |
Population-based survival of children in New Zealand diagnosed with cancer during 1990–1993
|
Douglas, N.M.
|
|
2005
|
41 |
11 |
p. 1604-1609
6 p.
|
article
|
| 19 |
Reply to the Letter to the Editor by Hughes in response to the article entitled “Multicentre randomised Phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced NSCLC”, published in vol. 41 Issue 1 of the European Journal of Cancer
|
Martoni, Andrea
|
|
2005
|
41 |
11 |
p. 1656-1657
2 p.
|
article
|
| 20 |
Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer
|
Borst, Gerben R.
|
|
2005
|
41 |
11 |
p. 1533-1541
9 p.
|
article
|
| 21 |
Strategies to improve outcomes of children with cancer in low-income countries
|
Howard, Scott C.
|
|
2005
|
41 |
11 |
p. 1584-1587
4 p.
|
article
|
| 22 |
The emerging family of hepatoblastoma tumours: From ontogenesis to oncogenesis
|
Zimmermann, Arthur
|
|
2005
|
41 |
11 |
p. 1503-1514
12 p.
|
article
|
| 23 |
The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC)
|
Ng, Matthew
|
|
2005
|
41 |
11 |
p. 1542-1546
5 p.
|
article
|
| 24 |
The mechanism of action of Kahalalide F: Variable cell permeability in human hepatoma cell lines
|
Sewell, J.M.
|
|
2005
|
41 |
11 |
p. 1637-1644
8 p.
|
article
|
| 25 |
The prevalence of PIK3CA mutations in gastric and colon cancer
|
Velho, Sérgia
|
|
2005
|
41 |
11 |
p. 1649-1654
6 p.
|
article
|
| 26 |
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroid
|
Magrath, I.
|
|
2005
|
41 |
11 |
p. 1570-1583
14 p.
|
article
|
| 27 |
Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: The role of promoter methylation of TSC genes
|
Jiang, Wen G.
|
|
2005
|
41 |
11 |
p. 1628-1636
9 p.
|
article
|
Journal description